カイノスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/01/12 | 1,108 | 1,119 | 1,093 | 1,113 | +9 | +0.8% | 11,300 |
2024/01/11 | 1,113 | 1,113 | 1,094 | 1,104 | -5 | -0.5% | 3,800 |
2024/01/10 | 1,110 | 1,117 | 1,092 | 1,109 | +5 | +0.5% | 5,400 |
2024/01/09 | 1,105 | 1,115 | 1,055 | 1,104 | -3 | -0.3% | 17,300 |
2024/01/05 | 1,104 | 1,119 | 1,104 | 1,107 | +3 | +0.3% | 8,700 |
2024/01/04 | 1,091 | 1,104 | 1,091 | 1,104 | +13 | +1.2% | 3,800 |
2023/12/29 | 1,110 | 1,114 | 1,090 | 1,091 | -7 | -0.6% | 5,500 |
2023/12/28 | 1,084 | 1,100 | 1,078 | 1,098 | +14 | +1.3% | 6,700 |
2023/12/27 | 1,086 | 1,121 | 1,083 | 1,084 | -7 | -0.6% | 22,200 |
2023/12/26 | 1,086 | 1,094 | 1,085 | 1,091 | +1 | +0.1% | 6,300 |
2023/12/25 | 1,095 | 1,095 | 1,085 | 1,090 | -5 | -0.5% | 2,800 |
2023/12/22 | 1,086 | 1,097 | 1,079 | 1,095 | +7 | +0.6% | 13,900 |
2023/12/21 | 1,098 | 1,098 | 1,083 | 1,088 | +1 | +0.1% | 22,300 |
2023/12/20 | 1,089 | 1,090 | 1,085 | 1,087 | -1 | -0.1% | 3,300 |
2023/12/19 | 1,099 | 1,099 | 1,088 | 1,088 | -12 | -1.1% | 3,200 |
2023/12/18 | 1,090 | 1,100 | 1,080 | 1,100 | +20 | +1.9% | 18,200 |
2023/12/15 | 1,079 | 1,087 | 1,072 | 1,080 | +1 | +0.1% | 2,100 |
2023/12/14 | 1,090 | 1,090 | 1,079 | 1,079 | -10 | -0.9% | 2,900 |
2023/12/13 | 1,093 | 1,093 | 1,085 | 1,089 | +4 | +0.4% | 1,500 |
2023/12/12 | 1,090 | 1,090 | 1,082 | 1,085 | +1 | +0.1% | 2,700 |
2023/12/11 | 1,100 | 1,100 | 1,083 | 1,084 | -6 | -0.6% | 8,200 |
2023/12/08 | 1,081 | 1,093 | 1,070 | 1,090 | +1 | +0.1% | 8,500 |
2023/12/07 | 1,088 | 1,090 | 1,081 | 1,089 | -3 | -0.3% | 1,000 |
2023/12/06 | 1,088 | 1,093 | 1,082 | 1,092 | +4 | +0.4% | 2,300 |
2023/12/05 | 1,097 | 1,102 | 1,087 | 1,088 | -22 | -2% | 6,400 |
2023/12/04 | 1,108 | 1,125 | 1,108 | 1,110 | +2 | +0.2% | 11,000 |
2023/12/01 | 1,077 | 1,125 | 1,074 | 1,108 | +32 | +3% | 47,000 |
2023/11/30 | 1,079 | 1,079 | 1,065 | 1,076 | -5 | -0.5% | 2,300 |
2023/11/29 | 1,086 | 1,086 | 1,057 | 1,081 | -5 | -0.5% | 4,700 |
2023/11/28 | 1,090 | 1,098 | 1,084 | 1,086 | -14 | -1.3% | 2,000 |
2023/11/27 | 1,091 | 1,101 | 1,090 | 1,100 | +10 | +0.9% | 12,600 |
2023/11/24 | 1,089 | 1,090 | 1,085 | 1,090 | +2 | +0.2% | 3,900 |
2023/11/22 | 1,083 | 1,088 | 1,078 | 1,088 | +2 | +0.2% | 3,600 |
2023/11/21 | 1,088 | 1,090 | 1,080 | 1,086 | -6 | -0.5% | 9,900 |
2023/11/20 | 1,084 | 1,094 | 1,084 | 1,092 | +8 | +0.7% | 6,900 |
2023/11/17 | 1,070 | 1,088 | 1,059 | 1,084 | +13 | +1.2% | 4,000 |
2023/11/16 | 1,071 | 1,078 | 1,064 | 1,071 | ±0 | ±0% | 2,500 |
2023/11/15 | 1,055 | 1,079 | 1,051 | 1,071 | +17 | +1.6% | 6,000 |
2023/11/14 | 1,074 | 1,074 | 1,035 | 1,054 | -20 | -1.9% | 12,100 |
2023/11/13 | 1,101 | 1,101 | 1,057 | 1,074 | -20 | -1.8% | 18,300 |
2023/11/10 | 1,050 | 1,100 | 1,050 | 1,094 | +49 | +4.7% | 45,900 |
2023/11/09 | 1,036 | 1,048 | 1,035 | 1,045 | +13 | +1.3% | 5,400 |
2023/11/08 | 1,039 | 1,040 | 1,032 | 1,032 | -9 | -0.9% | 2,500 |
2023/11/07 | 1,037 | 1,045 | 1,037 | 1,041 | -4 | -0.4% | 3,700 |
2023/11/06 | 1,042 | 1,063 | 1,042 | 1,045 | +5 | +0.5% | 7,500 |
2023/11/02 | 1,033 | 1,049 | 1,033 | 1,040 | +7 | +0.7% | 6,200 |
2023/11/01 | 1,028 | 1,035 | 1,024 | 1,033 | +7 | +0.7% | 10,400 |
2023/10/31 | 1,022 | 1,027 | 1,022 | 1,026 | +3 | +0.3% | 1,200 |
2023/10/30 | 1,027 | 1,032 | 1,023 | 1,023 | -3 | -0.3% | 2,100 |
2023/10/27 | 1,024 | 1,030 | 1,024 | 1,026 | +1 | +0.1% | 1,600 |
301~
350
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カイノス | 118,400円 | +6.8% | -13.8% | 2.96% | 9.07倍 | 0.77倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
モダリス | 7,800円 | - | - | 0.00% | - | 1.63倍 |
|
遺伝子治療薬の創薬ベンチャー、DNA切断しないエピゲノム編集に強み。研究開発中心は米国 |
ティムス | 14,200円 | - | - | 0.00% | - | 1.93倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国CORXEL社に導出 |
クリングル | 78,700円 | +240.0% | - | 0.00% | - | 2.58倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
カルナバイオ | 25,900円 | +13.5% | - | 0.00% | - | 2.00倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム